RecruitingPhase 2NCT06840899

CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury

Cannabinoid Modulation for Neurogenic Lower Urinary Tract Dysfunction in Spinal Cord Injury

Sponsor

University of Wisconsin, Madison

Enrollment

20 participants

Start Date

Feb 13, 2026

Study Type

INTERVENTIONAL

Conditions

Urinary Incontinence Spinal Cord Injury Supra-sacral Spinal Cord Injury

Summary

The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI). Participants will take Epidiolex (purified CBD) for 90 days

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called CBD for people with spinal cord injury, supra-sacral spinal cord injury, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCBD

Twice daily 100mg cannabidiol (CBD)

Locations(1)

University of Wisconsin - Madison

Madison, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06840899

Related Trials

Effectiveness of Virtual Bodily Illusion Intervention in Upper Limb Motor Function in People With Incomplete Spinal Cord Injury.

NCT051429431 location

Transcutaneous Spinal Electrical Stimulation to Improve Exercise Function After Spinal Cord Injury.

NCT076921911 location